| Literature DB >> 32597133 |
Oleksandr Y Tkachenko1, Ganna M Shayakhmetova1, Anatoliy V Matvienko1, Valentina M Kovalenko1.
Abstract
There is compelling evidence that a hypercaloric, high-fructose diet can cause metabolic syndrome (MetS) and a whole range of other metabolic changes. In the context of androgen deficiency, MetS in boys merits special attention, but the effects of fructose-rich diet in youth on future male reproductive function are still poorly evidenced. The aim of this study was to address this issue and analyse the effects of high-fructose intake starting from weaning to puberty (postnatal day 23 up to 83) on the reproductive function of male rats. For this purpose juvenile male Wistar rats were divided in two groups: control and the group receiving 10 % fructose solution instead of drinking water. Reproductive function was evaluated in terms of fertility, sperm count, testes/epididymis morphology, and serum sex hormones. The fructose-treated group showed a decrease in testosterone and twofold increase in luteinising and follicle-stimulating hormone levels in the serum. This was accompanied with lower testis/epididymis weights, sperm count, and changed testis/epididymis morphology. Their fertility remained unchanged, but the fertility of females mating with these males diminished. In addition, pre-implantation and post-implantation embryonic death rate rose in these females. Our results have confirmed that high fructose consumption from early age until puberty can impair the reproductive function of male rats, and call for further animal and epidemiological investigation.Entities:
Keywords: FSH; LH; MetS; epididymis; fertility; male reproductive function; metabolic syndrome; sperm count; testes; testosterone
Year: 2020 PMID: 32597133 PMCID: PMC7837242 DOI: 10.2478/aiht-2020-71-3303
Source DB: PubMed Journal: Arh Hig Rada Toksikol ISSN: 0004-1254 Impact factor: 1.948
Comparison of serum sex hormone levels between the high-fructose-treated and control group
| Parameters | Groups | ||
|---|---|---|---|
| Control | High-fructose | ||
| T (nmol/L) | 14.69 14.96(12.09±3.10 | 9.34 (10.25; 12.25) | 0.024* |
| LH (ng/mL) | 0.301±0.231) | 0.691±0.189 | 0.003* |
| FSH (ng/mL) | 0.077 0.10(0.044±0.06 | 0.218 (0.171; 0.235) | 0.021* |
* significantly different; T– testosterone; LH – luteinising hormone; FSH – follicle-stimulating hormone. Normally distributed data are presented as means ± standard deviations and geometric mean (95th confidence intervals); Data not distributed normally are reported as medians and interquartile ranges (IQR)
Comparison of gonad weight, volume, and sperm counts between the high-fructose-treated and control group
| Groups | |||
|---|---|---|---|
| Parameters | Control | High-fructose | |
| Testes absolute weight (g) | 3.48 3.49(3.31±0.24 | 3.20 3.21(3.06±0.19 | 0.014* |
| Testes relative weight (% of body weight) | 1.16 1.17(1.10±0.08–1.23) | 1.27 1.28(1.15±0.17 | 0.09 |
| Testes volume (cm3) | 3.79 3.81(3.53±0.39 | 3.34 3.37(3.05±0.45 | 0.029* |
| Epididymis absolute weight (g) | 0.96 (0.95; 0.98) | 0.88 0.88(0.81±0.11 | 0.047* |
| Epididymis relative weight (% of body weight) | 0.32 0.33(0.30±0.04 | 0.35 0.35(0.32±0.02 | 0.217 |
| Sperm count (million/mL) | 68.43 70.26(53.23±6.96 | 52.01 52.57(46.31±3.19 | 0.046* |
* significantly different. Normally distributed data are presented as means ± standard deviations and geometric mean (95th confidence intervals); Data not distributed normally are reported as medians and interquartile ranges (IQR)
Spermatogenesis epithelium findings
| Parameters | Groups | ||
|---|---|---|---|
| Control | High-fructose | ||
| Spermatogenesis index (stages of spermatogenesis total / number of examined tubules) | 3.44±0.21 | 3.34±0.05 | <0.001* |
| Number of spermatogonia (per tubular cross section) | 71.83±5.43 | 59.80±4.24 | <0.001* |
| Cells at the 12th stage of spermatogenesis (%) | 4.00 (3.0; 4.5) | 2.53 2.83(2.03±1.21 | 0.008* |
| Exfoliation of epithelium (%) | 1.0 (1.0; 2.0) | 2.5 (1.5; 3.0) | 1.000 |
* significantly different. Normally distributed data are presented as means ± standard deviations and geometric mean (95th confidence intervals); Data not distributed normally are reported as medians and interquartile ranges (IQR)
Figure 1Photomicrographs of rat testes stained with haematoxylin and eosin; (A) normal structure of seminiferous tubules in control rats (200x magnification); (B) focal dystrophic changes in spermatogonia (spg) and primary spermatocytes (spc) in HF rats (400x magnification); (C) spermatogenic epithelium exfoliation into the lumens of seminiferous tubules in HF rats (200x magnification); (D) decrease in the number of spermatogenic epithelium layers and expansion of the seminiferous tubules in HF rats (400x magnification)
Figure 2Photomicrographs of rats epididymis stained with haematoxylin and eosin; (A and B) normal epididymis tubule structure in control rats (100x and 400x magnification, respectively); (C) focal luminal sperm stasis in HF rats (100x magnification); (D) epithelial clear cell hyperplasia in HF rats (400x magnification)
Fertilising capacity of male rats
| Groups | Number of mated females | Number of pregnant females | Fertilising capacity |
|---|---|---|---|
| Control | 42 | 38 | 91 % |
| High-fructose group | 42 | 41 | 98 % |
| - | - | 0.809 | |
Fertility rate of unexposed females mated with HF males
| Groups | Parameters | |
|---|---|---|
| Total number of foetuses | Number of foetuses per female | |
| Control | 319 | 9.5 (7.5; 10.5) |
| High-fructose group | 300 | 9 (6; 9) |
| - | 0.092 | |
Data are reported as medians and interquartile ranges (IQR)
Effects of paternal high-fructose treatment on embryogenesis/foetogenesis in unexposed females on day 20 of gestation
| Groups | |||
|---|---|---|---|
| Parameters | Control | High-fructose | |
| Number of pregnant females (N) | 38 | 41 | - |
| Total number of corpora lutea (N) | 362 | 394 | - |
| Number of corpora lutea per female (N) | 10.5 (8.5; 11) | 10 (9; 11) | 1.000 |
| Preimplantational loss (N /%) | 25 / 10 | 60 / 15 | 0.012* |
| Preimplantational loss per female (N) | 0 (0; 1) | 1 (0; 2) | 0.028* |
| Postimplantational loss (N /%) | 6 / 2 | 19 / 6 | 0.013* |
| Postimplantational loss per female (N) | 0 (0; 0) | 0 (0; 1) | 0.041* |
| Total embryonal/foetal death (%) | 11.88 | 23.86 | <0.001* |
* significantly different. Data are reported as medians and interquartile ranges (IQR)